Regional Intelligence Command Center
Real-time denial patterns, payer intelligence, and contract negotiation data across US markets
National Avg Denial Rate
22.8%
Across all payers & categories
Avg Appeal Overturn
24.7%
Successful reversals on appeal
Highest Denial State
NC
29.6% denial rate
Most Favorable State
NY
14.7% denial rate
Market Overview — State-Level Denial Rates
| State | Region | Denial Rate | Trend | Overturn Rate | Avg Resolution Days | Top Denial Reason |
|---|---|---|---|---|---|---|
| CA | West | 24.3% | 15.9% | 17.2% | 30 days | Not Medically Necessary |
| TX | South | 18.9% | 3.8% | 28.4% | 38 days | Insufficient Medical Documentation |
| FL | South | 26.3% | 6.4% | 35.5% | 47 days | Insufficient Medical Documentation |
| NY | Northeast | 14.7% | 4.4% | 23.5% | 54 days | Not Medically Necessary |
| PA | Northeast | 22.1% | 2.4% | 21% | 33 days | Failed Step Therapy |
| IL | Midwest | 28.2% | 14.4% | 15.5% | 56 days | Failed Step Therapy |
| OH | Midwest | 20.1% | 2.9% | 15.9% | 25 days | Out of Network Provider |
| GA | South | 23.1% | 1.3% | 33.5% | 38 days | Insufficient Medical Documentation |
| NC | South | 29.6% | 8.6% | 15.2% | 40 days | Insufficient Medical Documentation |
| MI | Midwest | 23.7% | 0.5% | 27.1% | 53 days | Lack of Clinical Justification |
| NJ | Northeast | 15.2% | 7.2% | 25.2% | 26 days | Failed Step Therapy |
| VA | South | 17.9% | 0.3% | 37% | 40 days | Out of Network Provider |
| WA | West | 26.2% | 14.6% | 16.5% | 44 days | Lack of Clinical Justification |
| AZ | West | 26.8% | 4.6% | 36.7% | 46 days | Experimental Treatment |
| MA | Northeast | 25.2% | 3.6% | 22.3% | 41 days | Out of Network Provider |
Payer Comparison Matrix — Denial Rates by CPT Category
| Payer | Imaging Denial Rate | Market Share | 6M Trend | Total Claims | Comparative Position |
|---|---|---|---|---|---|
| UnitedHealthcare | 25.9% | 0.7% | ↓ 10.0% | 5,916 | Stricter than avg |
| Anthem BCBS | 13.8% | 15.1% | ↑ 5.1% | 13,023 | More lenient than avg |
| Aetna | 26.2% | 6.4% | ↑ 11.9% | 19,754 | Stricter than avg |
| Cigna | 26.2% | 13.0% | ↑ 3.5% | 6,204 | Stricter than avg |
| Humana | 27.3% | 3.2% | ↓ 1.9% | 17,479 | Stricter than avg |
| Blue Cross | 13.0% | 2.3% | ↑ 9.6% | 11,403 | More lenient than avg |
| State Medicaid | 22.1% | 18.0% | ↑ 7.4% | 16,531 | Stricter than avg |
| Medicare (CMS) | 12.7% | 8.3% | ↓ 6.3% | 15,897 | More lenient than avg |
Plan-Level Intelligence
Drill into specific health plans for detailed denial metrics and appeal strategies
UnitedHealthcare Plan 1
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
UnitedHealthcare Plan 2
UnitedHealthcare
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 1
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Anthem BCBS Plan 2
Anthem BCBS
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 1
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Aetna Plan 2
Aetna
Top Denial Reasons:
1. Insufficient Medical Documentation
2. Not Medically Necessary
3. Failed Prior Authorization
Regional Policy Changes & Trending Alerts
UnitedHealthcare Imaging Denial Surge
Imaging denials increased 8.3% YoY. New prior auth requirements effective March 2026.
Anthem Step Therapy Expansion
Anthem expanding step therapy to infusion/biologics. Biologic approvals require 8-week conventional trial.
Medicaid Approval Trend Positive
State Medicaid programs showing 3.2% improvement in appeal overturn rates.
Contract Negotiation Ammunition
Data-backed negotiation talking points by payer
UnitedHealthcare — Imaging Overreach
- • Imaging denial rate: 24.3% (national avg: 22.8%)
- • YoY increase: +8.3% — highest among major competitors
- • Appeal overturn rate: 18.2% suggests denials not clinically justified
- • Benchmark: Aetna imaging denials at 16.7%, demonstrating more rational approach
Anthem — Overly Aggressive Step Therapy
- • Infusion/biologic denial rate: 28.5% (payer avg: 18.3%)
- • New 8-week conventional therapy requirement adds 40+ days to approval
- • Blue Cross plan competing on your network approves at 14.2% denial rate
- • Consider network reduction penalty clause in RFP response
Regional Opportunity — Texas/FL Markets
- • Texas denial rate: 14.2% (lowest in South region)
- • Florida Medicaid: 22.8% denial rate but 32% appeal overturn
- • Negotiation lever: "Your denial rates trailing regional peers by 6.1%"
- • Opportunity: Volume rebates if deny rate improves to regional median
Benchmark Comparison — Appeal Economics
- • National appeal success rate: 24.7%
- • High-denial payers (>20%) showing appeal success of 25%+
- • Cost to hospitals: $500-1,000 per appeal dispute
- • Propose: Monthly denial reconciliation calls to reduce appeals by 30%
Network Performance Benchmarks
How your hospital network compares to regional peers
Your Network (Simulated)
16.2%
Overall denial rate
Regional Peer Average
18.4%
200-300 bed hospitals, same region
Best-in-Class Benchmark
11.8%
Top 10% of networks nationally
Position: Your denial rate is 2.2 percentage points better than regional peers. With targeted clinical documentation improvements, best-in-class position is achievable within 6 months. This translates to ~$280K in recovered revenue annually based on current claim volume.